Analytical Data
-
Gene name
MYOZ2
- Application
-
Alternative Names
MYOZ2；C4orf5；Myozenin-2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NPC6
-
Expression Region
1-264aa
-
AA Sequence
MLSHNTMMKQRKQQATAIMKEVHGNDVDGMDLGKKVSIPRDIMLEELSHL SNRGARLFKMRQRRSDKYTFENFQYQSRA QINHSIAMQNGKVDGSNLE GGSQQAPLTPPNTPDPRSPPNPDNIAPGYSGPLKEIPPEKFNTTAVPKYY QSPWEQAISNDPELLEALYPKLFKPEGKAELPDYRSFNRVATPFGGFEKA SRMVKFKVPDFELLLLTDPRFMSFVNPLSGRRSFNRTPKGWISENIPIVI TTEPTDDTTVPESEDLLEHHHHHH
-
Molecular Weight
31 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYOZ2, a member of the myozenin family, is primarily expressed in skeletal muscle and plays a crucial role in linking myofibrils and the sarcoplasmic reticulum, thus contributing to muscle contraction and maintenance. Recent studies have suggested that MYOZ2 may have significant implications in muscle development, repair, and overall muscle function. Abnormalities in MYOZ2 expression have been associated with various muscular disorders, making it a potential biomarker for muscle-related diseases. Researchers have increasingly focused on the recombinant production of MYOZ2 to analyze its structure-function relationships and to explore its role in cellular mechanisms involved in muscle physiology. By utilizing recombinant DNA technology, scientists can produce MYOZ2 in controlled laboratory settings, allowing for detailed functional assays, interaction studies, and potential therapeutic applications. Understanding the dynamics of MYOZ2 through recombinant protein studies could provide insights into muscle pathologies and contribute to the development of targeted therapies for muscle degenerative diseases, thereby enhancing recovery strategies and muscle health in various clinical settings.
